Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Catheter ablation versus sotalol versus flecainide + verapamil for idiopathic ventricular premature beats/ventricular tachycardia
NL-OMON48860Active, not recruiting
- Sponsor
- Cardiologie Zwolle
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of sotalol, flecainide and verapamil in Premature ventricular complexes (PVC) and Idiopathic Ventricular Tachycardia (IVT) (3 arms), sponsored by Cardiologie Zwolle. Primary endpoint: VPB/VT burden reduction after 3 months. Started Feb 2019; status: active, not recruiting.
02
Drugs
sotalolflecainideverapamil
03
Conditions
Premature ventricular complexes (PVC)Idiopathic Ventricular Tachycardia (IVT)
Beyond the preview
Go deeper on NL-OMON48860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48860.